ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Indiana » Child Adolescent Psychiatry

Top Child Adolescent Psychiatry Prescribers in Indiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
SANJAY MISHRA MD

Child Adolescent Psychiatry

3,043

$444K

179
52 are 65+

15%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 28%

$146
Average prescription price

Avg: $155

LIA KETTENIS M.D.

Child Adolescent Psychiatry

2,898

$508K

150
12 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 28%

$175
Average prescription price

Avg: $155

MITCHELL GOLDSTEIN M.D.

Child Adolescent Psychiatry

2,764

$356K

161
28 are 65+

16%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 28%

$129
Average prescription price

Avg: $155

KUMUD AGGARWAL MD

Child Adolescent Psychiatry

2,740

$401K

142
12 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 0%

22%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 28%

$146
Average prescription price

Avg: $155

ELIZABETH TAYLOR DO

Child Adolescent Psychiatry

1,752

$378K

97
41 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 0%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

44%
prescriptions for brand name drugs

Avg: 28%

$215
Average prescription price

Avg: $155

DANIEL KINSEY M.D.

Child Adolescent Psychiatry

1,746

$304K

154
23 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 28%

$174
Average prescription price

Avg: $155

DALE SOMMERS M.D.

Child Adolescent Psychiatry

1,632

$163K

84
14 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 0%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 28%

$100
Average prescription price

Avg: $155

TERESITA BRIONES-RAMILO M.D.

Child Adolescent Psychiatry

1,601

$290K

80
14 are 65+

15%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

47%
prescriptions for brand name drugs

Avg: 28%

$181
Average prescription price

Avg: $155

JOHN SCHILTZ M.D., PH.D.

Child Adolescent Psychiatry

1,552

$261K

79
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 28%

$168
Average prescription price

Avg: $155

DESPINA MOISE MD

Child Adolescent Psychiatry

1,149

$180K

66
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 28%

$156
Average prescription price

Avg: $155

MARTIN PLAWECKI M.D., PH.D.

Child Adolescent Psychiatry

1,123

$161K

94
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 28%

$143
Average prescription price

Avg: $155

SYED KHAN MD

Child Adolescent Psychiatry

946

$151K

152
15 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 28%

$159
Average prescription price

Avg: $155

CHRISTHART SCHILBACH MD

Child Adolescent Psychiatry

712

$85K

63
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 28%

$119
Average prescription price

Avg: $155

KRISTIN SMITH MD

Child Adolescent Psychiatry

437

$48.4K

103
30 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 28%

$111
Average prescription price

Avg: $155

GINA LAITE M.D.

Child Adolescent Psychiatry

366

$51.6K

38
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 28%

$141
Average prescription price

Avg: $155

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank